PTC Therapeutics Announces Topline Results from Vatiquinone MOVE-FA Registration-Directed Trial
Industry News
News|May 15 2023
Larimar Therapeutics Reports Preliminary Top-line Data from Phase 2 Trial’s 25 mg Cohort – First Quarter 2023 Financial Results
Industry News
News|May 15 2023
Larimar Therapeutics Reports Preliminary Top-line Data from Phase 2 Trial’s 25 mg Cohor
Industry News
News|May 15 2023
Larimar Therapeutics Reports Preliminary Top-line Data from Phase 2 Trial’s 25 mg Cohort Showing Increases in Frataxin Levels in Patients with Friedreich’s Ataxia and First Quarter 2023 Financial Results
Industry News
Blog|May 8 2023
Meet the Community – Alijana Shakya
Community
News|Apr 30 2023
April 2023 – Advocacy Newsletter
Advocacy
Blog|Apr 23 2023
Meet the Community 2: A Closer Look – Helen Kearney
Community
Blog|Apr 9 2023
Meet the Community – Reetam Mukherjee
Community
Blog|Apr 2 2023
Meet the Community 2: A Closer Look – Brittany Wiseman
Community
Blog|Mar 26 2023
Meet the Community 2: A Closer Look – Dr. Georg Herdt